Compare Enzyme (MLN) vs Streamflow (STREAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Streamflow — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Streamflow trades at Rp144.83 (market cap Rp38,3M, Rp1,17M 24h volume). The key difference: Enzyme is far larger — about 3.5× Streamflow's market cap, and Streamflow's supply is capped (254,5M / 1B STREAM (26%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Streamflow for 28 Days on average.
| MLN | STREAM | |
|---|---|---|
Market Cap | Rp134,13M | Rp38,3M |
Volume (24h) | Rp104,56M | Rp1,17M |
Circulating Supply | 3,3M MLN | 254,5M / 1B STREAM (26%) |
Typical Hold Time | 29 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Streamflow (STREAM) presents a unique profile with a market cap of Rp38.3M and a circulating supply of 254.5 million tokens out of a fixed maximum of 1 billion, indicating a 26% circulation rate. The token shows relatively low market activity with a 28-day average hold time suggesting longer-term holding patterns. Current technical positioning shows limited trading data available, requiring careful monitoring of emerging trends and volume patterns.
Overall outlook remains cautious due to limited market data and liquidity. Key opportunities include potential ecosystem growth if protocol adoption increases, while major risks center around low trading volume, regulatory uncertainty in the crypto space, and the inherent volatility of small-cap digital assets. Investors should monitor for increased exchange liquidity and protocol developments.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Streamflow
Streamflow provides secure, user-friendly, and robust token infrastructure to create and distribute tokens across their entire lifecycle—from launch to maturity. By solving incentive misalignment, Streamflow ensures sustainable token economies.
Read more on STREAM →
